Skip to content

Multicenter Cohort Study on Developing Short- and Long-term Prognosis Prediction Models for Ischemic Stroke via Integrating Multi-dimensional Data Based on the Concept of Clinlabomics

Multicenter Cohort Study on Developing Short- and Long-term Prognosis Prediction Models for Ischemic Stroke via Integrating Multi-dimensional Data Based on the Concept of Clinlabomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118104
Enrollment
Unknown
Registered
2026-02-02
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the clinical diagnostic criteria for acute ischemic stroke according to the 2023 edition of the "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke"; 2. Age >=18 years; 3. Diagnosed with a first-ever ischemic stroke based on cranial CT or cranial MRI imaging examinations.

Exclusion criteria

Exclusion criteria: 1.Incomplete case data or basic patient information; 2.Complicated with severe diseases: Severe dysfunction of vital organs (e.g., New York Heart Association [NYHA] functional class III–IV, end-stage liver disease, uremia, etc.); advanced malignant tumors; severe pulmonary diseases (e.g., acute exacerbation of chronic obstructive pulmonary disease [AECOPD], respiratory failure, etc.); severe systemic infection or sepsis; 3.Patients with cognitive impairment or a history of mental disorders; 4.Pregnancy or lactation: Females in the period of pregnancy or lactation; 5.Patients who received reperfusion therapy or anticoagulant therapy during hospitalization; 6.Patients with a history of previous stroke; 7.Patients who refused to participate in follow-up; 8.Patients with poor compliance, who discontinued secondary preventive medications during the follow-up period; 9.Missing rate of clinical/laboratory data exceeding 30%.

Design outcomes

Primary

MeasureTime frame
Major Disability;

Secondary

MeasureTime frame
Recurrence;

Countries

China

Contacts

Public ContactJiang Yao

Suining Central Hospital

774555460@qq.com+86 18308316169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026